Noncompaction cardiomyopathy biopsy

Noncompaction Cardiomyopathy Microchapters
Home
Patient Info
Overview
Historical Perspective
Classification & Nomenclature
Pathophysiology
Genetics
Embryology
Histology
Left Ventricular Dysfunction
Arrhythmias
Thromboembolism
Neuromuscular Disorders
Epidemiology & Demographics
Screening
Natural History, Complications & Prognosis
Differentiating Noncompaction Cardiomyopathy from other Diseases
Diagnosis
History & Symptoms
Physical Examination
Laboratory Studies
Genetic Testing
Electrocardiogram
Holter Monitoring
Chest X Ray
MRI
CT
Echocardiography
Biopsy
Treatment
Medical Therapy
Surgery
Noncompaction cardiomyopathy biopsy On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Noncompaction cardiomyopathy biopsy
CDC on Noncompaction cardiomyopathy biopsy
Noncompaction cardiomyopathy biopsy in the news
Blogs on Noncompaction cardiomyopathy biopsy
Directions to Hospitals Treating Type page name here
Risk calculators and risk factors for Noncompaction cardiomyopathy biopsy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Both skeletal and cardiac biopsies may reveal abnormal histologic findings.

Skeletal Biopsy

A skeletal biopsy can be performed which may demonstrate inclusion bodies or myopathic changes .

Cardiac Biopsy

• Interstitial fibrosis was observed in 5/5 patients with isolated noncompaction cardiomyopathy who underwent right ventricular biopsy
• Endomyocardial thickening and subendocardial fibroelastosis was observed in 3/5 patients who underwent right ventricular biopsy